Your browser doesn't support javascript.
loading
Antifibrotic therapies in rheumatoid arthritis associated interstitial lung disease.
Bes, Cemal; Köybasi, Gizem; Içaçan, Ozan Cemal; Yalçin Mutlu, Melek; Yildirim, Fatih.
Afiliação
  • Bes C; Department of Internal Medicine and Rheumatology, University of Health Sciences, Basaksehir Çam and Sakura City Hospital, Istanbul, Turkey.
  • Köybasi G; Department of Chest Disease, Yedikule Chest Diseases and Chest Surgery Training and Research Hospital, Istanbul, Turkey.
  • Içaçan OC; Department of Rheumatology, University of Health Sciences, Bakirko¨ y Dr. Sadi Konuk, Training and Research Hospital, Istanbul, Turkey.
  • Yalçin Mutlu M; Department of Internal Medicine and Rheumatology, University of Health Sciences, Basaksehir Çam and Sakura City Hospital, Istanbul, Turkey.
  • Yildirim F; Department of Internal Medicine and Rheumatology, University of Health Sciences, Basaksehir Çam and Sakura City Hospital, Istanbul, Turkey.
Eur J Rheumatol ; 9(3): 176-179, 2022 07.
Article em En | MEDLINE | ID: mdl-35156636
ABSTRACT
Interstitial lung disease (ILD) is one of the common extra-articular manifestations of rheumatoid arthritis (RA) and it is associated with high mortality rate. The usual interstitial pneumonia (UIP) pattern of RA associated ILD (RA-ILD) shows some similarities to idiopathic pulmonary fibrosis, suggesting that antifibrotic therapies may have potential positive affects. In this review, we discuss the effectiveness of antifibrotic therapy for RA-ILD.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Doenças Pulmonares Intersticiais Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Doenças Pulmonares Intersticiais Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article